1. Home
  2. ALT vs NVTS Comparison

ALT vs NVTS Comparison

Compare ALT & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • NVTS
  • Stock Information
  • Founded
  • ALT 1997
  • NVTS 2014
  • Country
  • ALT United States
  • NVTS United States
  • Employees
  • ALT N/A
  • NVTS N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • NVTS Semiconductors
  • Sector
  • ALT Health Care
  • NVTS Technology
  • Exchange
  • ALT Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • ALT 457.0M
  • NVTS 473.3M
  • IPO Year
  • ALT N/A
  • NVTS N/A
  • Fundamental
  • Price
  • ALT $8.41
  • NVTS $2.02
  • Analyst Decision
  • ALT Buy
  • NVTS Buy
  • Analyst Count
  • ALT 7
  • NVTS 8
  • Target Price
  • ALT $20.00
  • NVTS $4.75
  • AVG Volume (30 Days)
  • ALT 4.3M
  • NVTS 3.2M
  • Earning Date
  • ALT 11-12-2024
  • NVTS 11-04-2024
  • Dividend Yield
  • ALT N/A
  • NVTS N/A
  • EPS Growth
  • ALT N/A
  • NVTS N/A
  • EPS
  • ALT N/A
  • NVTS N/A
  • Revenue
  • ALT $52,000.00
  • NVTS $91,381,000.00
  • Revenue This Year
  • ALT N/A
  • NVTS $8.34
  • Revenue Next Year
  • ALT N/A
  • NVTS $5.50
  • P/E Ratio
  • ALT N/A
  • NVTS N/A
  • Revenue Growth
  • ALT N/A
  • NVTS 38.99
  • 52 Week Low
  • ALT $2.50
  • NVTS $1.75
  • 52 Week High
  • ALT $14.84
  • NVTS $8.44
  • Technical
  • Relative Strength Index (RSI)
  • ALT 58.51
  • NVTS 43.21
  • Support Level
  • ALT $6.95
  • NVTS $1.75
  • Resistance Level
  • ALT $11.16
  • NVTS $1.88
  • Average True Range (ATR)
  • ALT 0.93
  • NVTS 0.16
  • MACD
  • ALT 0.02
  • NVTS -0.02
  • Stochastic Oscillator
  • ALT 41.51
  • NVTS 28.72

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: